Viewing Study NCT00003193


Ignite Creation Date: 2025-12-25 @ 1:19 AM
Ignite Modification Date: 2026-01-20 @ 9:53 AM
Study NCT ID: NCT00003193
Status: COMPLETED
Last Update Posted: 2012-12-06
First Post: 1999-11-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Sponsor: Massachusetts General Hospital
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: CDR0000066028
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators